Veradigm | MDRX - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Alcidion AUD 23.27M 565K 2025-12
Ambu A/S DKK 1.4B 6M 2026-03
Amplifon EUR 525.51M 75.35M 2026-03
Cardinal Health USD -2.83B 52M 2026-03
Centene USD 21.43B 29.53B 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Cigna USD 42.21B 497.12M 2026-03
Coloplast 5.19B 185M 2025-12
Computer Programs Systems USD 207.2M 119.28M 2025-12
Convatec Group USD 1B 518M 2024-12
CVS Health USD 95.75B 7.84B 2026-03
Diasorin EUR 231M 511K 2026-03
Elevance Health USD 43.9B 5.26B 2026-03
General Electric Aerospace USD 18.06B 7.11B 2026-03
Gulf Medical Proj AED 182.97M 16.46M 2025-12
Humana USD 37.89B 4.57B 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Laboratory Of America USD 3.13B 6.3M 2026-03
Maximus USD 1.7B 22.85M 2026-03
McKesson USD 94.46B 10.04B 2026-03
Med Life RON 747.87M 6.92M 2025-09
Molina Healthcare USD 4.08B 7.45B 2026-03
Omnicell USD 292.84M 19.96M 2026-03
Oriola-kd EUR 45.4M 451.2M 2026-03
Owens Minor USD -464.76M 1.17B 2026-03
Quest Diagnostics USD 2.5B 76M 2026-03
Rede D'or Sao Luiz BRL 11.43B 385.31M 2026-03
Siemens Healthineers EUR 4.95B 229M 2026-03
Sonova Holding CHF 1.52B 59.9M 2025-12
Supermax Corporation Bhd MYR 167.61M 83.39M 2026-03
UnitedHealth USD 102.68B 7.27B 2026-03
Veeva Systems USD 609.84M 19.76M 2026-03
Veradigm USD 188M 61.08M 2022-12
Xerox USD 299M 145M 2026-03